Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 1
2020 1
2021 2
2022 2
2023 1
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.
Palmerini E, Sapienza MR, Pileri SA, Frega G, Righi A, Parafioriti A, Franchi A, Agostinelli C, Righi S, Meazza C, Ferraresi V, Asaftei SD, Coccoli L, Tamburini A, Gambarotti M, Serra M, Donati DM, Fagioli F, Cesari M, Carretta E, Scotlandi K, Ibrahim T, Laginestra MA. Palmerini E, et al. Among authors: coccoli l. Clin Cancer Res. 2025 Sep 15;31(18):3932-3943. doi: 10.1158/1078-0432.CCR-25-0649. Clin Cancer Res. 2025. PMID: 40711479
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.
Luksch R, Palmerini E, Milano GM, Paioli A, Asaftei S, Barretta F, Puma N, Cesari M, Tirtei E, Podda M, Pierobon M, Manzitti C, Ferraresi V, Tamburini A, Bertulli R, Di Pinto D, Mascarin M, Grignani G, Coccoli L, Rabusin M, De Leonardis F, Gambarotti M, Parafioriti A, Cammelli S, Vennarini S, Ferrari S, Donati DM, Bastoni S, Massimino M, Fagioli F, Ibrahim T. Luksch R, et al. Among authors: coccoli l. Pediatr Blood Cancer. 2025 Apr;72(4):e31551. doi: 10.1002/pbc.31551. Epub 2025 Jan 20. Pediatr Blood Cancer. 2025. PMID: 39833645 Clinical Trial.
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.
Palmerini E, Meazza C, Tamburini A, Márquez-Vega C, Bisogno G, Fagioli F, Ferraresi V, Milano GM, Coccoli L, Rubio-San-Simón A, Gallego O, Llinares Riestra ME, Manzitti C, Mora J, Vaz-Salgado MÁ, Luksch R, Mata C, Pierini M, Carretta E, Cesari M, Paioli A, Marrari A, Scotlandi K, Serra M, Asaftei SD, Gambarotti M, Picci P, Ferrari S, Valverde C, Ibrahim T, Broto JM. Palmerini E, et al. Among authors: coccoli l. J Clin Oncol. 2025 Oct;43(28):3113-3122. doi: 10.1200/JCO-25-00210. Epub 2025 Aug 18. J Clin Oncol. 2025. PMID: 40825172 Free PMC article.
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers.
Ferrari A, Perillo T, Milano GM, Silva M, Rutigliano C, Salvo A, Livellara V, Conte M, Coccoli L, Amore E, Pierobon M, Vietina F, Pagani Bagliacca E, Spinelli M, Massei MS, Massetti V, Legnani E, Puglisi I, Zucchetti G, Quarello P. Ferrari A, et al. Among authors: coccoli l. Tumori. 2024 Aug;110(4):218-226. doi: 10.1177/03008916241245005. Epub 2024 Apr 9. Tumori. 2024. PMID: 38591573
Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study.
Tirtei E, Campello A, Sciannameo V, Asaftei SD, Meazza C, Sironi G, Longhi A, Ibrahim T, Tamburini A, Coccoli L, Crocco F, Cagnazzo C, De Luna E, Quarello P, Berchialla P, Fagioli F. Tirtei E, et al. Among authors: coccoli l. BMC Cancer. 2024 Jun 19;24(1):747. doi: 10.1186/s12885-024-12498-x. BMC Cancer. 2024. PMID: 38898388 Free PMC article.
The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series.
Santangelo A, Bartolini E, Nuzzi G, Foiadelli T, Michev A, Mina T, Trambusti I, Fichera V, Bonuccelli A, Massimetti G, Peroni DG, De Marco E, Coccoli L, Luti L, Bernasconi S, Nardi M, Menconi MC, Casazza G, Pruna D, Mura R, Marra C, Zama D, Striano P, Cordelli DM, Battini R, Orsini A. Santangelo A, et al. Among authors: coccoli l. Front Neurol. 2022 Jun 10;13:920214. doi: 10.3389/fneur.2022.920214. eCollection 2022. Front Neurol. 2022. PMID: 35756920 Free PMC article.
Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Palmerini E, Meazza C, Tamburini A, Bisogno G, Ferraresi V, Asaftei SD, Milano GM, Coccoli L, Manzitti C, Luksch R, Serra M, Gambarotti M, Donati DM, Scotlandi K, Bertulli R, Favre C, Longhi A, Abate ME, Perrotta S, Mascarin M, D'Angelo P, Cesari M, Staals EL, Marchesi E, Carretta E, Ibrahim T, Casali PG, Picci P, Fagioli F, Ferrari S. Palmerini E, et al. Among authors: coccoli l. Cancer. 2022 May 15;128(10):1958-1966. doi: 10.1002/cncr.34131. Epub 2022 Feb 24. Cancer. 2022. PMID: 35201621 Free PMC article. Clinical Trial.
15 results